Polymorphisms at exon 4 of p53 and the susceptibility to herpesvirus types 6 and 1 infection in renal transplant recipients

Transplant International

Volumn 19, Issue 9, 2006, Pages 732-737

  Leite, Janaína L ^a   Manfrinatto, Juliana A ^a   Mazzali, Marilda ^a   Ward, Laura S ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Laboratory of Cancer Molecular Genetics   (Brazil)

Author keywords

Codon 47; Codon 72; Herpesvirus; p53 gene; Renal transplant recipients

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CODON; CONTROLLED STUDY; EXON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HERPES SIMPLEX VIRUS 1; HIGH RISK PATIENT; HUMAN; HUMAN HERPESVIRUS 6; INFECTION SENSITIVITY; INHERITANCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; WILD TYPE;

ADULT; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; ROSEOLOVIRUS INFECTIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33746890853     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00346.x     Document Type: Article

References (29)

1. Pass R. Herpesvirus infections in transplant recipients. Herpes 2000; 7: 3.
2. Shackelford J, Pagano JS. Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination. Mol Cell Biol 2004; 24: 5089.
3. Whitman AG, Hamden KE, Ford PW, McCubrey JA, Akula SM. Role for Raf in the entry of viruses associated with AIDS. Int J Oncol 2004; 25: 469.
4. Lane DP. p53, guardian of the genome. Nature 2002; 358: 15.
5. Yasukawa M, Inoue Y, Ohminami H, Terada K, Fujita S. Apoptosis of CD4+ T lymphocytes in human herpesvirus-6 infection. J Gen Virol 1998; 79: 143.
6. Secchiero P, Flamand L, Gibellini D, et al. Human herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood 1997; 90: 4502.
7. Winkler MT, Doster A, Jones C. Bovine herpesvirus 1 can infect CD4(+) T lymphocytes and induce programmed cell death during acute infection of cattle. J Virol 1999; 73: 8657.
8. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6: 443.
9. Dumont P, Leu JI, Della Pietra AC, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357.
10. Li X, Dumont P, Della Pietra A, Shetler C, Murphy ME. The codon 47 polymorphism in p53 is functionally significant. Biol Chem 2005; 280: 24245.
11. Leite JL, Stolf HO, Reis NA, Ward LS. Human herpesvirus type 6 and type 1 infection increases susceptibility to nonmelanoma skin tumors. Cancer Lett 2005; 224: 213.
12. Granja F, Morari J, Morari EC, Correia LA, Assumpção LVM, Ward LS. Proline homozygozity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett 2004; 210: 151.
13. Smith SR, Butterly DW, Alexander BD, Greenberg A. Viral infections after transplantation. Am J Kidney Dis 2001; 37: 659.
14. Ketteler M, Kunter U, Floege J. An update on herpes virus infections in graft recipients. Nephrol Dial Transplant 2003; 18: 1703.
15. Gentile G. Post-transplant HHV-6 diseases. Herpes 2000; 7: 24.
16. Yoshikawa T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 2003; 7: 11.
17. Meyers JD, Wade JC, Mitchell CD, et al. Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med 1982; 73: 229.
18. Jenkins FJ, Rowe DT, Rinaldo Jr CR. Herpesvirus infections in organ transplant recipients. Clin Diag Lab Immunol 2003; 10: 1.
19. Cleaver JE. Mechanisms by which human cells bypass damaged bases during DNA replication after ultraviolet irradiation. Sci World J 2002; 14: 1296.
20. Robles AI, Harris CC. p53-mediated apoptosis and genomic instability diseases. Acta Oncol 2001; 40: 696.
21. Takemoto M, Mori Y, Ueda K, Kondo K, Yamanishi K. Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol 2004; 85: 869.
22. Flaitz CM, Hicks MJ. Molecular piracy: the viral link to carcinogenesis. Oral Oncol 1998; 34: 448.
23. Muralidhar S, Doniger J, Mendelson E, et al. Human cytomegalovirus MTRII oncoprotein binds to p53 and down-regulates p53-activated transcription. J Virol 1996; 70: 8691.
24. Ichimi R, Jin-No T, Ito M. Induction of apoptosis in cord blood lymphocytes by HHV-6. J Med Virol 1999; 58: 63.
25. Inoue Y, Yasukawa M, Fujita S. Induction of T-cell apoptosis by human herpesvirus 6. J Virol 1997; 71: 3751.
26. Yasukawa M, Inoue Y, Ohminami H, Terada K, Fujita S. Apoptosis of CD4 T lymphocytes in human herpesvirus-6 infection. J Gen Virol 1998; 79: 143.
27. Takemoto M, Shimamoto T, Isegawa Y, Yamanishi K. The R3 region, one of three major repetitive regions of human herpesvirus 6, is a strong enhancer of immediate-early gene U95. J Virol 2001; 75: 10149.
28. Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet 1993; 53: 752.
29. Marty FM, Rubin RH. The prevention of infection posttransplant: the role of prophylaxis, preemptive and empiric therapy. Transpl Int 2006; 19: 2.